Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial

Published:2013-08-15 Issue:10 Volume:33 Page:755-760
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Zhu Yi,Zhang Guangyun,Zhao Jun,Li Deshuai,Yan Xiaodong,Liu Juanfang,Liu Xuedong,Zhao Haibo,Xia Jielai,Zhang Xiao,Li Zhengyi,Zhang Baorong,Guo Zongcheng,Feng Lianyuan,Zhang Zhaodong,Qu Fang,Zhao Gang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-013-0121-x.pdf

Reference39 articles.

1. Naylor AR. Letter by Naylor regarding article, “Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association”. Stroke. 2011;42(6):e385; author reply e386.

2. Wood H. Stroke: could the neuroprotective drug NA-1 limit ischaemic brain damage after stroke? Nat Rev Neurol. 2012;8(12):658.

3. Blanco M, Castillo J. Stroke in 2012: major advances in the treatment of stroke. Nat Rev Neurol. 2013;9(2):68–70.

4. Kingwell K. Stroke: neuroprotection for patients with stroke moves one step closer to the clinic. Nat Rev Neurol. 2012;8(4):178.

5. Cook DJ, Teves L, Tymianski M. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature. 2012;483(7388):213–7.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meldonium, as a potential neuroprotective agent, promotes neuronal survival by protecting mitochondria in cerebral ischemia–reperfusion injury;Journal of Translational Medicine;2024-08-15

2. Novel energy optimizer, meldonium, rapidly restores acute hypobaric hypoxia-induced brain injury by targeting phosphoglycerate kinase 1;Cell Communication and Signaling;2024-07-29

3. Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes;Molecular Neurobiology;2024-07-09

4. Unlocking the Potential of Meldonium: From Performance Enhancement to Therapeutic Insights;Psychoactives;2024-05-06

5. Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma;Pharmaceuticals;2023-04-15